“Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases -2/-9 via ROS/ERK1/2 pathways” (2014) Bangladesh Journal of Pharmacology, 9(3), pp. 419–427. doi:10.3329/bjp.v9i3.19730.